[go: up one dir, main page]

WO1999046379A3 - Human receptor proteins; related reagents and methods - Google Patents

Human receptor proteins; related reagents and methods Download PDF

Info

Publication number
WO1999046379A3
WO1999046379A3 PCT/US1999/003735 US9903735W WO9946379A3 WO 1999046379 A3 WO1999046379 A3 WO 1999046379A3 US 9903735 W US9903735 W US 9903735W WO 9946379 A3 WO9946379 A3 WO 9946379A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
receptor proteins
human receptor
related reagents
reagents
Prior art date
Application number
PCT/US1999/003735
Other languages
French (fr)
Other versions
WO1999046379A2 (en
Inventor
Christi L Parham
Kevin W Moore
Nicholas J Murgolo
J Fernando Bazan
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Priority to CA002323236A priority Critical patent/CA2323236A1/en
Priority to JP2000535746A priority patent/JP2002505879A/en
Priority to AU28718/99A priority patent/AU2871899A/en
Priority to EP99909534A priority patent/EP1062332A2/en
Publication of WO1999046379A2 publication Critical patent/WO1999046379A2/en
Publication of WO1999046379A3 publication Critical patent/WO1999046379A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Nucleic acids encoding mammalian, e.g., primate or rodent receptors, purified receptor proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are provided.
PCT/US1999/003735 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods WO1999046379A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002323236A CA2323236A1 (en) 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods
JP2000535746A JP2002505879A (en) 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods
AU28718/99A AU2871899A (en) 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods
EP99909534A EP1062332A2 (en) 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3739498A 1998-03-09 1998-03-09
US09/037,394 1998-03-09

Publications (2)

Publication Number Publication Date
WO1999046379A2 WO1999046379A2 (en) 1999-09-16
WO1999046379A3 true WO1999046379A3 (en) 1999-10-21

Family

ID=21894109

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/003735 WO1999046379A2 (en) 1998-03-09 1999-03-08 Human receptor proteins; related reagents and methods

Country Status (5)

Country Link
EP (1) EP1062332A2 (en)
JP (1) JP2002505879A (en)
AU (1) AU2871899A (en)
CA (1) CA2323236A1 (en)
WO (1) WO1999046379A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60030769T2 (en) 1999-12-23 2007-10-25 Zymogenetics, Inc., Seattle PROCESS FOR TREATMENT OF IGNITION
DE60045139D1 (en) * 1999-12-23 2010-12-02 Zymogenetics Inc Soluble interleukin-20 receptor
US6610286B2 (en) 1999-12-23 2003-08-26 Zymogenetics, Inc. Method for treating inflammation using soluble receptors to interleukin-20
US7122632B2 (en) 1999-12-23 2006-10-17 Zymogenetics, Inc. Soluble Interleukin-20 receptor
ATE360696T1 (en) 2000-06-30 2007-05-15 Zymogenetics Inc INTERFERON-LIKE PROTEIN ZCYTO21
ATE342980T1 (en) 2000-08-08 2006-11-15 Zymogenetics Inc SOLUBLE ZCYCTOR 11 CYTOKINE RECEPTORS
ATE460429T1 (en) 2000-09-15 2010-03-15 Zymogenetics Inc POLYPEPTIDES CONTAINING EXTRACELLULAR DOMAIN OF IL-20RA AND/OR IL-20RB
AU2002357643A1 (en) * 2001-08-29 2003-04-14 Vanderbilt University The human mob-5 (il-24) receptors and uses thereof
CA2467723C (en) 2001-12-17 2011-09-27 Zymogenetics, Inc. Method for treating cervical cancer
ATE475673T1 (en) 2003-03-24 2010-08-15 Zymogenetics Inc ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USE IN INFLAMMATION
ATE388963T1 (en) 2003-08-07 2008-03-15 Zymogenetics Inc HOMOGENEOUS PRODUCTIONS OF IL-29
US20050170468A1 (en) 2003-11-21 2005-08-04 Wenfeng Xu Anti-IL-20 receptor antibodies and binding partners and methods of using in inflammation
CN101198625A (en) 2004-10-22 2008-06-11 津莫吉尼蒂克斯公司 Anti-IL-22RA antibodies and binding partners and methods of using in inflammation
AU2011219715B2 (en) 2010-02-26 2014-12-11 Novo Nordisk A/S Stable antibody containing compositions
KR20130086144A (en) 2010-05-28 2013-07-31 노보 노르디스크 에이/에스 Stable multi-dose compositions comprising an antibody and a preservative

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005847A1 (en) * 1993-08-20 1995-03-02 University Of Medicine & Dentistry Of New Jersey Accessory factor function for interferon gamma and its receptor
WO1995016036A2 (en) * 1993-12-09 1995-06-15 Michel Aguet IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995005847A1 (en) * 1993-08-20 1995-03-02 University Of Medicine & Dentistry Of New Jersey Accessory factor function for interferon gamma and its receptor
WO1995016036A2 (en) * 1993-12-09 1995-06-15 Michel Aguet IFN-ηRECEPTOR β-CHAIN AND DERIVATIVES THEREOF

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002112563, Database accession no. AA455558 *
HEMMI S. ET AL.: "A novel member of the Interferon Receptor family complements functionality of the murine Interferon gamma Receptor in human cells", CELL, vol. 76, 11 March 1994 (1994-03-11), pages 803 - 810, XP002112561 *
PESTKA S.: "The Interferon Receptors", SEMINARS IN ONCOLOGY, vol. 24, no. 3 suppl. 9, June 1997 (1997-06-01), pages S9-18 - S9-40, XP002113151 *
SOH J. ET AL.: "Identification and sequence of an accessory factor required for activation of the human Interferon gamma Receptor", CELL, vol. 76, 11 March 1994 (1994-03-11), pages 793 - 802, XP002067347, ISSN: 0092-8674 *
ZUKER C. ET AL.: "Dictyostelium transposable element DIRS-1 has 350-base-pair inverted terminal repeats that contain a heat shock promoter", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE USA, vol. 81, May 1984 (1984-05-01), pages 2660 - 2664, XP002112562 *

Also Published As

Publication number Publication date
WO1999046379A2 (en) 1999-09-16
CA2323236A1 (en) 1999-09-16
AU2871899A (en) 1999-09-27
JP2002505879A (en) 2002-02-26
EP1062332A2 (en) 2000-12-27

Similar Documents

Publication Publication Date Title
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
WO2002020569A3 (en) Mammalian genes; related reagents and methods
AU6135101A (en) Mammalian receptor proteins; related reagents and methods
ZA200604026B (en) IL-23 and its receptor ; related reagents and methods
EP1433792A8 (en) Human receptor proteins, related reagents and methods
CY1109093T1 (en) Mammalian Receptor Proteins, Related Reagents, and Related Methods
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
EP2292760A3 (en) Mammalian cytokines, receptors, related reagents and methods
WO1999046379A3 (en) Human receptor proteins; related reagents and methods
PL336635A1 (en) Proteins of human tool-like receptor and their associated reagents and methods
EP2305715A3 (en) Monoclonal antibody to osteoprotegerin binding protein
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
HK1044023A1 (en) Ox2 receptor homologs
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
WO1999019480A3 (en) Human receptor proteins; related reagents and methods
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
WO2001046419A3 (en) Mammalian prion proteins; related reagents and methods
WO1998041538A3 (en) Novel human cytokine/steroid receptor protein
CY1114280T1 (en) ANTI-COMPETITIVE ANTI-COMPETITIVE ANTI-COMPETITIVE COMPETITORS OR THEIR RELIGIONS

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT UA UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GD GE HR HU ID IL IN IS JP KG KR KZ LC LK LR LT LU LV MD MG MK MN MX NO NZ PL PT RO RU SE SG SI SK SL TJ TM TR TT UA UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 535746

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref document number: 2323236

Country of ref document: CA

Ref country code: CA

Ref document number: 2323236

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/008848

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999909534

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999909534

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWR Wipo information: refused in national office

Ref document number: 1999909534

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1999909534

Country of ref document: EP